Difference between revisions of "Team:Cardiff Wales/silverfulfilment"
Ryancoates (Talk | contribs) |
|||
| Line 18: | Line 18: | ||
<p><b>1. Collaboration:</b> We have greatly enjoyed interacting with iGEM teams from around the World and we generated an important piece of data for the team from the the | <p><b>1. Collaboration:</b> We have greatly enjoyed interacting with iGEM teams from around the World and we generated an important piece of data for the team from the the | ||
| − | <a href="https://2017.igem.org/Team:Exeter"> University of Exeter</a>. | + | <a href="https://2017.igem.org/Team:Exeter"> University of Exeter</a>. In addition we had useful discussions about each others projects with the <a href="https://2017.igem.org/Team:Valencia_UPV">Valencia</a> and <a href="https://2017.igem.org/Team:WashU_StLouis">WashU</a> teams. These interactions are documented on our <a href="https://2017.igem.org/Team:Cardiff_Wales/Collaborations">collaborations</a> page.</p> |
<br><hr> | <br><hr> | ||
| − | <p><b>2. Human Practices:</b>We have engaged in a number of outreach events to publicise the potential of plant synthetic biology. These have included University Open days, school and public events. In addition we conducted a survey that assessed public attitudes to the use of genetically modified organisms for food or medicine. These are outlined on our <a href="https://2017.igem.org/Team:Cardiff_Wales/Public_outreach">public outreach</a> and <a href="https://2017.igem.org/Team:Cardiff_Wales/Survey">survey</a> pages. We also extensively communicated with professional plant bio-technologists for insight into using plants as a biofactory. This information was incorporated into our <a href="https://2017.igem.org/Team:Cardiff_Wales/Modelling">modelling</a>. </p> | + | <p><b>2. Human Practices:</b> We have engaged in a number of <a href="https://2017.igem.org/Team:Cardiff_Wales/Public_outreach">outreach events</a> to publicise the potential of plant synthetic biology. These have included University Open days, school and public events. <br>In addition we conducted a <a href="https://2017.igem.org/Team:Cardiff_Wales/Survey">survey</a> that assessed public attitudes to the use of genetically modified organisms for food or medicine. These are outlined on our <a href="https://2017.igem.org/Team:Cardiff_Wales/Public_outreach">public outreach</a> and <a href="https://2017.igem.org/Team:Cardiff_Wales/Survey">survey</a> pages. We also extensively communicated with professional plant bio-technologists for insight into using plants as a biofactory. This information was incorporated into our <a href="https://2017.igem.org/Team:Cardiff_Wales/Modelling">modelling</a>. </p> |
<br><hr> | <br><hr> | ||
| − | <p><b>3. Validated Parts:</b>We have generated a set of biobricks that contain a novel set of plant promotors in the Phytobrick standard. These are outlined on our <a href="https://2017.igem.org/Team:Cardiff_Wales/basicparts">parts page</a>. We tested these parts by expressing the Thyroid Stimulating Hormone antagonist (TSH) in the tobacco leaf expression system | + | <p><b>3. Validated Parts:</b> We have generated a set of biobricks that contain a novel set of plant promotors in the Phytobrick standard. These are outlined on our <a href="https://2017.igem.org/Team:Cardiff_Wales/basicparts">parts page</a>. We tested these parts by expressing the Thyroid Stimulating Hormone antagonist (TSH) in the tobacco leaf expression system. These parts are outlined on our <a href="https://2017.igem.org/Team:Cardiff_Wales/compositeparts">composite parts</a> pages and our attempts to express these proteins are outlined on the <a href="https://2017.igem.org/Team:Cardiff_Wales/results">Results</a> page as well as in our <a href+"https://2017.igem.org/Team:Cardiff_Wales/diary">lab diary</a>. |
<br><br><br><br> | <br><br><br><br> | ||
</p> | </p> | ||
Revision as of 16:20, 30 October 2017